The Safe Guide to Debridement in the Challenging Clinical Setting

We are delighted that Omni-Stat is featured in this article ‘The Safe Guide to Debridement in the Challenging Clinical Setting’ published in Wound Masterclass Volume 1: Issue 3 – Dec 2022.

In the article the author Dr Aliza Lee (Clinical Research Investigator at the Department of Veterans Affairs, Salem VA, United States) concludes:

Results of the case series presented here support the use of the chitosan-based hemostatic agent following guideline recommended sharp debridement to bleeding tissue in patients on anticoagulant therapy given its ability to achieve rapid hemostasis. In addition to the ability to achieve rapid hemostasis in this patient population, use of the chitosan-based hemostatic agent may help expedite wound resolution due to its ability to promote early advanced wound care product use and the potentially beneficial inherent properties of chitosan.

You can read the full article here on page 22.